ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1081

Administration of Patient Reported Outcome Measurement Information System (PROMIS) Instruments By Computer Adaptive Testing in Patients with Systemic Vasculitis

Gunnar Tomasson1, John T. Farrar2, David Cuthbertson3, Carol McAlear4, Susan Asdown5, Don Gebhart6, Georgia Lanier7, Nataliya Milman8, Jacqueline Peck9, Joanna Robson10, Simon Carette11, Gary S. Hoffman12, Nader A. Khalidi13, Curry L. Koening14, Carol A. Langford12, Larry W. Moreland15, Paul A. Monach16, Christian Pagnoux11, Ulrich Specks17, Antoine G. Sreih18, Steven R. Ytterberg19 and Peter A. Merkel4, 1Dept of Public Health Sciences, University of Iceland, Reykiavik, Iceland, 2Universitiy of Pennsylvania, Philadelphia, PA, 3Biostatistics and Informatics, Department of Pediatrics, University of South Florida, Tampa, FL, 4Penn Vasculitis Center, Division of Rheumatology, University of Pennsylvania, Philadelphia, PA, 5NONE, Branbury, United Kingdom, 6NONE, Columbus, OH, 7NONE, Framingham, MA, 8Division of Rheumatology, University of Ottawa, Ottawa, ON, Canada, 9Oxford University, Oxford, United Kingdom, 10Nuffield Department of Orthopaedics Rheumatology and Musculoskeletal Sciences, University of Oxford, University of Oxford, Oxford, United Kingdom, 11Mount Sinai Hospital, Toronto, ON, Canada, 12Rheumatology, Cleveland Clinic, Cleveland, OH, 13McMaster University, Hamilton, ON, Canada, 14Division of rheumatology, George E. Wahlen Department of Veterans Affairs Medical Center Salt Lake City and University of Utah, University of Utah School of Medicine, Salt Lake City, UT, 15Rheumatology & Clinical Immunology, University of Pittsburgh, Pittsburgh, PA, 16Rheumatology, Boston University School of Medicine, Boston, MA, 17Division of Pulmonary and Critical Care Medicine, Mayo Clinic College of Medicine, Rochester, MN, 18Department of Rheumatology, University of Pennsylvania, Philadelphia, PA, 19Rheumatology Division, Mayo Clinic, Rochester, MN

Meeting: 2015 ACR/ARHP Annual Meeting

Date of first publication: September 29, 2015

Keywords: PROMIS, Validity and outcome measures

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Sunday, November 8, 2015

Title: Vasculitis I

Session Type: ACR Concurrent Abstract Session

Session Time: 4:30PM-6:00PM

   Background/Purpose: Currently-used
outcome measures in vasculitis insufficiently capture the life impact of
systemic vasculitis from patients’ perspectives. The Patient Reported Outcome
Measurement Information System (PROMIS) is a collection of item banks designed to
cover a broad range of self-reported health. This study assessed the
feasibility and construct validity of selected PROMIS instruments in a
longitudinal cohort of patients with vasculitis.

   Methods: Data
from a multicenter longitudinal cohort of subjects with systemic vasculitis from
May 2014 to February 2015 were used. Instruments from 10 PROMIS item banks were
selected (Table 1) with direct involvement of patient research partners and
added to ongoing disease assessments. Each subject completed PROMIS instruments
from 6 item banks. PROMIS instruments were administered using computer adaptive
testing (CAT) intended to allow for a more precise estimate while minimizing
burden on study subjects. The Short Form 36 (SF-36) and physician and patient global
assessments for disease activity were also measured on an 11 point scale (0-10).
Active disease was defined as a physician global assessment >0. Cross-sectional
construct validity was assessed by calculating the correlations of PROMIS
scores with the other disease measures at baseline and longitudinal construct
validity was assessed by correlations of between-study visit differences in
PROMIS scores with differences in other disease measures.

   Results: 604
study subjects came for 899 study visits. PROMIS assessments were completed at
796 (88%) of the visits. The median time to complete the set of PROMIS
assessments was 8.7 minutes (IQR 6.1-12.1) for the total cohort, 15.2 minutes
(IQR 11.9-19.2) for those older than 80, and 6.7 (IQR 4.9-9.6, )) minutes for
those younger than 40. Mean PROMIS scores at baseline are shown in Table 1. PROMIS
instruments correlated cross-sectionally with the individual scales of the
SF-36, most strongly with subscales of the SF-36 addressing the same domain as
the PROMIS instrument. Weaker correlations were observed in differences of
scores longitudinally. The differences in all PROMIS scores during active
disease vs. remission were in the expected direction for each domain (Table 2).

   Conclusion:
PROMIS measures have cross-sectional construct validity and help discriminate
between active disease and remission. Inclusion of PROMIS instruments in disease
assessment in vasculitis would enhance capture of patients’ perspectives of disease
burden and complement traditional physician-based outcome measures.


Disclosure: G. Tomasson, None; J. T. Farrar, None; D. Cuthbertson, None; C. McAlear, None; S. Asdown, None; D. Gebhart, None; G. Lanier, None; N. Milman, None; J. Peck, None; J. Robson, None; S. Carette, None; G. S. Hoffman, None; N. A. Khalidi, None; C. L. Koening, None; C. A. Langford, None; L. W. Moreland, None; P. A. Monach, None; C. Pagnoux, None; U. Specks, None; A. G. Sreih, None; S. R. Ytterberg, None; P. A. Merkel, None.

To cite this abstract in AMA style:

Tomasson G, Farrar JT, Cuthbertson D, McAlear C, Asdown S, Gebhart D, Lanier G, Milman N, Peck J, Robson J, Carette S, Hoffman GS, Khalidi NA, Koening CL, Langford CA, Moreland LW, Monach PA, Pagnoux C, Specks U, Sreih AG, Ytterberg SR, Merkel PA. Administration of Patient Reported Outcome Measurement Information System (PROMIS) Instruments By Computer Adaptive Testing in Patients with Systemic Vasculitis [abstract]. Arthritis Rheumatol. 2015; 67 (suppl 10). https://acrabstracts.org/abstract/administration-of-patient-reported-outcome-measurement-information-system-promis-instruments-by-computer-adaptive-testing-in-patients-with-systemic-vasculitis/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2015 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/administration-of-patient-reported-outcome-measurement-information-system-promis-instruments-by-computer-adaptive-testing-in-patients-with-systemic-vasculitis/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology